v3.25.3
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Condensed Consolidated Statements of Comprehensive Loss [Abstract]        
License and collaborations revenue $ 3,079 $ 3,867 $ 10,331 $ 6,690
Operating expenses:        
General and administrative 4,981 2,894 17,093 10,918
Research and development 6,409 8,982 20,384 19,817
Total operating expenses 11,390 11,876 37,477 30,735
Loss from operations (8,311) (8,009) (27,146) (24,045)
Fair value change in warrant and other derivative liabilities (9,525) 0 (5,803) 0
Financing costs 0 0 (1,337) 0
Interest expense (68) 0 (68) 0
Other income, net 450 483 1,286 1,648
Loss before income taxes (17,454) (7,526) (33,068) (22,397)
Benefit (provision) for income taxes 0 0 0 0
Net loss (17,454) (7,526) (33,068) (22,397)
Other comprehensive loss, net of tax 0 0 0 0
Comprehensive loss $ (17,454) $ (7,526) $ (33,068) $ (22,397)
Net loss per share:        
Basic (in dollars per share) $ (0.25) $ (0.29) $ (0.59) $ (0.88)
Diluted (in dollars per share) $ (0.25) $ (0.29) $ (0.59) $ (0.88)
Number of shares used in per share calculations:        
Basic (in shares) 70,636,887 26,145,080 56,100,689 25,501,117
Diluted (in shares) 70,636,887 26,145,080 56,100,689 25,501,117

Source